Simplex Trading
SGMO

Simplex Trading’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Simplex Trading’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.13K Buy
+76,500
New +$17.9K ﹤0.01% 8279
2025
Q4 		– Sell
-9,609
Closed -$5.09K – 9909
2025
Q3 		$6K Sell
9,609
-115,724
-92% -$62.4K ﹤0.01% 8227
2025
Q2 		$67K Sell
125,333
-116,961
-48% -$69.5K ﹤0.01% 5629
2025
Q1 		$158K Buy
242,294
+49,756
+26% +$52.7K ﹤0.01% 4575
2024
Q4 		$196K Buy
192,538
+77,802
+68% +$142K ﹤0.01% 4540
2024
Q3 		$99K Buy
114,736
+70,832
+161% +$51.9K ﹤0.01% 5245
2024
Q2 		$15K Buy
43,904
+989
+2% +$534 ﹤0.01% 7144
2024
Q1 		$28K Buy
42,915
+11,934
+39% +$8.66K ﹤0.01% 6816
2023
Q4 		$16K Sell
30,981
-8,504
-22% -$3.92K ﹤0.01% 7103
2023
Q3 		$23K Sell
39,485
-11,945
-23% -$12.8K ﹤0.01% 6513
2023
Q2 		$66K Buy
51,430
+24,128
+88% +$33K ﹤0.01% 5548
2023
Q1 		$48K Buy
27,302
+16,731
+158% +$47.7K ﹤0.01% 5972
2022
Q4 		$33K Sell
10,571
-17,211
-62% -$66.8K ﹤0.01% 6347
2022
Q3 		$136K Buy
27,782
+15,788
+132% +$81.1K ﹤0.01% 5100
2022
Q2 		$49K Sell
11,994
-30,546
-72% -$132K ﹤0.01% 6519
2022
Q1 		$247K Sell
42,540
-10,012
-19% -$59.5K ﹤0.01% 4836
2021
Q4 		$394K Buy
52,552
+29,258
+126% +$254K ﹤0.01% 4147
2021
Q3 		$279K Buy
23,294
+300
+1% +$2.97K ﹤0.01% 5039
2021
Q2 		$275K Buy
22,994
+8,248
+56% +$93.4K ﹤0.01% 5139
2021
Q1 		$0 Sell
14,746
-46,066
-76% -$621K ﹤0.01% 9898
2020
Q4 		$948K Buy
60,812
+31,640
+108% +$371K ﹤0.01% 2630
2020
Q3 		$275K Sell
29,172
-35,068
-55% -$379K ﹤0.01% 3705
2020
Q2 		$575K Buy
64,240
+40,558
+171% +$376K ﹤0.01% 2743
2020
Q1 		$150K Sell
23,682
-31,045
-57% -$230K ﹤0.01% 3922
2019
Q4 		$458K Buy
54,727
+3,438
+7% +$31.6K ﹤0.01% 2835
2019
Q3 		$464K Buy
51,289
+630
+1% +$7.07K ﹤0.01% 2696
2019
Q2 		$545K Buy
50,659
+41,209
+436% +$438K ﹤0.01% 2480
2019
Q1 		$90K Sell
9,450
-30,730
-76% -$314K ﹤0.01% 4458
2018
Q4 		$461K Buy
40,180
+23,220
+137% +$288K ﹤0.01% 2311
2018
Q3 		$287K Sell
16,960
-33,783
-67% -$513K ﹤0.01% 3233
2018
Q2 		$720K Buy
50,743
+343
+0.7% +$5.7K ﹤0.01% 2102
2018
Q1 		$957K Buy
+50,400
New +$1.08M 0.04% 409
2017
Q2 		– Sell
-1,605
Closed -$10.3K – 6717
2017
Q1 		$8K Buy
+1,605
New +$6.44K ﹤0.01% 4195
2016
Q1 		– Sell
-12,368
Closed -$74.3K – 6162
2015
Q4 		$112K Buy
12,368
+3,744
+43% +$28.9K 0.01% 1268
2015
Q3 		$48K Buy
+8,624
New +$71.1K ﹤0.01% 2034
2015
Q2 		– Sell
-26,946
Closed -$347K – 5786
2015
Q1 		$422K Buy
26,946
+22,677
+531% +$351K 0.05% 380
2014
Q4 		$65K Buy
+4,269
New +$51.8K 0.01% 1185

Other funds holding SGMO

NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
AIM
Axiom Investment Management New York $150M AUM
FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
HIG
Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Simplex Trading's SGMO Position: Q2 2026 in Review

Simplex Trading opened a new position in SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026: 76,500 shares worth $4.13K. The stake represents ﹤0.01% of the portfolio and ranks #8279 among its holdings. This is a return to the name: Simplex Trading previously reported a position in SGMO as recently as Q3 2025.

Simplex Trading first reported a position in SGMO in Q4 2014 and has held it in 37 quarters since. The position peaked at $957K in Q1 2018. 6 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

  • Simplex Trading held 76,500 shares of SANGAMO THERAPEUTICS INC worth $4.13K as of Q2 2026.
  • SANGAMO THERAPEUTICS INC was a new Simplex Trading position in Q2 2026.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #8279 holding.
  • Simplex Trading first reported a position in SANGAMO THERAPEUTICS INC in Q4 2014 and has held it in 37 quarters since.
  • Simplex Trading's SANGAMO THERAPEUTICS INC position peaked at $957K in Q1 2018.
  • 6 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.